General PD Knowledge
Mechanisms of PD
Impacts of PD
Current Treatments and Research
Drugs Under Clinical Trial
100

What type of disorder is Parkinson’s Disease (PD)?

A neurodegenerative disorder primarily affecting dopamine-producing neurons in the substantia nigra

100

What is the function of α-synuclein under normal conditions?

Synaptic vesicle dynamics and mitochondrial function.

100

What aspect of aging is most affected by PD?

Mobility and independence due to neurodegeneration.

100

What role does exercise play in managing PD?

Improves quality of life and helps manage symptoms.

100

What is Tavapadon, and what does it aim to treat?

A dopamine receptor partial agonist to reduce motor symptoms

200

Name two environmental factors linked to Parkinson’s Disease

Dietary habits, toxin exposure, smoking, or caffeine consumption

200

What happens when α-synuclein accumulates in PD?

Forms toxic aggregates like oligomers and fibrils, disrupting cellular systems.

200

How does PD impact caregivers emotionally?

Causes stress, emotional strain, and increased rates of depression and anxiety.

200

Name a supportive therapy for PD patients.

Physical therapy, occupational therapy, or speech therapy.

200

What does IRL790 target?

t modulates dopamine receptors to reduce motor symptoms

300

What are common motor symptoms of Parkinson’s Disease?

Tremors, slow movements, limb stiffness, and balance issues

300

Which two mitochondrial complexes are key sites of ROS production in PD?

Complexes I and III

300

Name one cognitive effect of PD

Memory loss, risk of dementia, or cognitive processing slowdowns.

300

What surgical intervention helps reduce motor symptoms in PD?

Deep Brain Stimulation (DBS)

300

How does Deferiprone work to slow PD progression?

It binds and removes excess iron, targeting the ferroptosis pathway

400

What is the prevalence of Parkinson’s Disease globally?

Over 10 million people worldwide.

400

How does oxidative stress link to α-synuclein aggregation?

It impairs lysosomal autophagy, accelerating α-synuclein toxicity.

400

How does mitochondrial dysfunction contribute to PD’s biological impacts?

Causes energy deficits and accelerates neuronal damage.

400

What is the “gold standard” pharmacological treatment for PD?

Levodopa

400

What is the purpose of Prasinezumab?

An antibody targeting α-synuclein to reduce its aggregation.

500

What is a non-motor symptom associated with advanced Parkinson’s Disease?

Cognitive decline, depression, anxiety, or autonomic dysfunction.

500

What triggers ferroptosis in Parkinson’s Disease?

Abnormal iron metabolism and severe lipid peroxidation

500

What financial challenges do families of PD patients face?

High costs of medical care and reduced income due to caregiving responsibilities

500

What are the three treatments types for PD?

Pharmacological, surgical, and lifestyle therapies

500

Why is Tavapadon undergoing further trials?

To evaluate its long-term effectiveness and safety.

M
e
n
u